SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-19-003923
Filing Date
2019-12-06
Accepted
2019-12-06 18:42:01
Documents
1
Period of Report
2019-12-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4097
  Complete submission text file 0001683168-19-003923.txt   5648
Mailing Address C/O XENETIC BIOSCIENCES, INC. 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address
PARSLOW JAMES F (Reporting) CIK: 0001285943 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37937 | Film No.: 191274029

Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Issuer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations